Blog

The Norwegian Nobel Institute is pictured in Oslo, Norway on September 25, 2024.Jonathan Nackstrand | Afp | Getty ImagesJapanese atomic bomb survivor organization Nihon Hidankyo won the Nobel Peace Prize on Friday in recognition of the organization's efforts to achieve a world free of nuclear weapons."This grassroots movement of atomic bomb survivors from Hiroshima and Nagasaki, also known as Hibakusha, is receiving the peace prize for its efforts to achieve a world free of nuclear weapons and for demonstrating through witness testimony that nuclear weapons must never be used again," the Norwegian Nobel Committee said in a statement.The Norwegian Nobel Institute said 286 candidates were registered to be considered for this year's prize, of which 197 were individuals and 89 were organizatio...

Zahra Bahrololoumi, CEO of U.K. and Ireland at Salesforce, speaking during the company's annual Dreamforce conference in San Francisco, California, on Sept. 17, 2024.David Paul Morris | Bloomberg | Getty ImagesLONDON — The UK chief executive of Salesforce wants the Labor government to regulate artificial intelligence — but says it's important that policymakers don't tar all technology companies developing AI systems with the same brush.Speaking to CNBC in London, Zahra Bahrololoumi, CEO of UK and Ireland at Salesforce, said the American enterprise software giant takes all legislation "seriously." However, she added that any British proposals aimed at regulating AI should be "proportional and tailored."Bahrololoumi noted that there's a difference between companies developing consumer-facing...

Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly.CEO Adam Steensberg told CNBC Thursday that early-stage trials of its experimental obesity injection point to higher-quality weight loss — with reduced muscle loss and fewer side effects — versus traditional GLP-1 treatments. The company is now scouting for a global pharma firm to partner with, he added."Our focus is really what's needed in the 2030s, and it's really about establishing, you can say, the next-generation molecules that are not based on GLP-1s," Steensberg said.Last month, Zealand Pharma announced positive top-line results from a phase 1b trial of its weight-loss drug, a GLP-1/GLP-2 receptor dual agonist c...

Alexander Spatari | Moment | Getty ImagesLONDON — The U.K. economy grew 0.2% in August on a month-on-month basis, flash figures published by the Office for National Statistics showed Friday.Gross domestic product (GDP) came in line with the expectations of economists polled by Reuters, who had forecast growth of 0.2%.Britain's economic growth was up 0.2% in the three months to August, compared with the 0.5% recorded in the three months to July.The U.K.'s dominant services sector showed slight growth of 0.1% in the month to August, while production and construction output rose by 0.5% and 0.4%, respectively.The country's economy flatlined in June and July, after previously recording modest but steady expansion in almost every month this year. Britain emerged from a shallow recession at the ...